A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

InfertilityAnovulation

Interventions

DRUG

DA-3801 Injection

DRUG

Gonal-F®

Trial Locations (1)

Seoul National University Hospital Institutional Review Board, Seoul

All Listed Sponsors

lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT01820728 - A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F® | Biotech Hunter | Biotech Hunter